Posted by Michael Wonder on 18 May 2020
Seelos Therapeutics receives rare paediatric disease designation for SLS-005 (trehalose) in Sanfilippo syndrome
15 May 2020 - Seelos Therapeutics today announced it has been granted rare paediatric disease designation for SLS-005 in Sanfilippo syndrome from the U.S. FDA.
Seelos was also recently granted orphan disease designation from the FDA for SLS-005 in Sanfilippo syndrome.
